Author

Y. Mujadidi

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Persistence of immune responses 5 years after vaccination with a single dose of typhoid conjugate vaccine (TCV) in Nepalese children.

BACKGROUND A single-dose typhoid conjugate vaccine (TCV) has been recommended in endemic settings. Here we report the 5-year immunogenicity results post a single dose of TCV in Nepal. METHODS We conducted a participant- and observer-blinded randomised trial (RCT) in Lalitpur, Nepal (2017-2021) (ISRCTN43385161). 20,01...

D. Pant, Yi-Yuan Zhang, Francesca Feaheny et al. · Vaccine · 0 citations

Review Open access Aug 2026

8-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in children in Nepal (TyVOID): a prospective cohort follow-up study of the TyVAC Nepal randomised controlled trial.

BACKGROUND In low-income and middle-income countries, where typhoid fever remains a major public health problem, WHO recommends the use of typhoid conjugate vaccine (TCV). Here, we report vaccine effectiveness up to 8 years following a single dose of TCV in Nepal. METHODS TyVOID was a prospective cohort study that ex...

D. Pant, Yi-Yuan Zhang, F. W. Basile et al. · Lancet Global Health · 1 citation

Open access Jul 2026

ChAdOx1 nCoV-19 coronavirus vaccine: Long-term safety and immunological responses.

RATIONALE Follow-up of pre-licensure trial participants potentially informs a vaccine's long-term safety profile. DESIGN This prospective study enrolled participants from the first clinical trials of ChAdOx1 nCoV-19 vaccine, many of whom subsequently received COVID-19 vaccines in the UK vaccination programme. Serious...

Narges Ebrahimi, Philip de Whalley, Nasir Kanji et al. · Vaccine · 0 citations